Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia

Inclusion Criteria: * Covid-19 patients with pneumonia or bacteremia/septicemia who have culture-confirmed bacterial co-infection with A. baumannii, P. aeruginosa or S. aureus. * Patient provided informed and signed consent. Exclusion Criteria: * Patient eligible for another APT sponsored trial. * Patient participating in another clinical trial at the same time or patients \< 4 weeks from participating in an alternative investigational protocol/study * Patient with known allergy to infusion of phage products * Patients with a history of Meningitis or encephalitis at time of study entry, Primary immune deficiency disease or tuberculosis or Stroke, transient ischemic attack (TIA), or untreated deep vein thrombosis.